Back to Search

SREENIVASA NATTAM, MD

MD

Hematology & Oncology Physician

NPI: 1982606893IndividualAccepts Medicare

Specialties, Licenses & Credentials

Medical Oncology Physician

Internal Medicine — Medical Oncology

Code: 207RX0202X

01030857A(IN)
Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

01030857A(IN)

CMS Specialties

PrimaryHEMATOLOGY/ONCOLOGY

Education

OTHER

Class of 1974

Research & Publications (9)

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
PMID 19201650·Lancet Oncol·2009
3-trial
Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan: a randomized phase 2 trial by the Cancer and Leukemia Group B (CALGB 19803).
PMID 19025972·Cancer·2009
3-trial
Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
PMID 19060586·Am J Clin Oncol·2008
3-trial
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.
PMID 19001323·J Clin Oncol·2008
3-trial
Treatment of elderly non-small cell lung cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomized trial.
PMID 17409863·J Thorac Oncol·2006
3-trial
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
PMID 16258101·J Clin Oncol·2005
3-trial
A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer.
PMID 15151950·Ann Oncol·2004
3-trial
Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation.
PMID 12885812·J Clin Oncol·2003
3-trial
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
PMID 11252888·Oncology (Williston Park)·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2514 E DUPONT RD STE 100
FORT WAYNE, IN 46825

Location

Practice Location

2514 E DUPONT RD STE 100, FORT WAYNE, IN
(260) 484-8830

Quick Facts

NPI
1982606893
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
52
Publications
9

Are you this provider?

Claim Your Profile